ABVC - ABVC BioPharma, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
2.65 0.04 (1.51%) --- 0.0 (0.0%) -0.02 (-0.74%) 0.0 (0.0%) -0.02 (-0.74%) 0.0 (0.0%) 0.05 (1.76%)

ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.06
Diluted EPS:
-0.06
Basic P/E:
-44.8333
Diluted P/E:
-44.8333
RSI(14) 1m:
50.0
VWAP:
2.69
RVol:

Events

Period Kind Movement Occurred At

Related News